Drug surveillance programme

A footnote explains that the drug surveillance programme is supported in part by 10 different drug companies, at least one of which makes an SSRI. However, Eli Lilly was not among them. 

Anonymous. Oral contraceptives aud veuous thromboembolic disease, surgically coufirmed gallbladder disease, aud breast tumours. Report from the Bostou Collaborative Drug Surveillance Programme. Laucet 1973 l(7817) 1399-404. 

Boston Collaborative Drug Surveillance Programme. Excess of ampicillin rashes associated with allopurinol or hyperuricemia.(1972) 286,505-7. 

Boston Collaborative Drug Surveillance Programme. Allopurinol and cytotoxic drugs. Interaction in relation to bone marrow depression. JAMA (1974) 227,1036-40. 

Boston collaborative drug surveillance programm (1973) Drug-induced anaphylaxis a comparative study. JAMA 224 613... 

Boston Collaborative Drug Surveillance Programme (1973) Oral contraceptives and venous thromboembolie disease, surgically confirmed gall bladder disease, and breast tumors. Lancet, 1. 1399. 

This chapter will review the way in which veterinary pharmaceutical drugs are used and the controls placed on their use. It will also explain how information from veterinary drug residues surveillance programmes coupled with knowledge of the potential risk they pose can be used to assess the hazards they may present if allowed to enter the human food chain. 

The UK national surveillance programmes for residues of veterinary drugs in meat and animal products... 

The Statutory Surveillance Programme implements European Union (EU) legislation in accordance with the provisions set out in Directive 96/23/EEC. This Directive sets out the sampling regime and the veterinary drugs that must be monitored by each EU member state. 

In other nations similar bodies exist for the surveillance of veterinary drug residues in food. Any country that is not a member of the EU, wishing to export meat or animal products into the EU, must have a residues surveillance programme that is compatable with EU legislation. 

The implementation of legislation in the UK has ensured more effective control over residues than has previously been possible. This will help to deter an isolated number of farmers who do not observe the recommended conditions of use for veterinary products and who are therefore probably responsible for the low number of residue violations recorded. Refinements in analytical methodology, to improve the speed and reliability of residue detection, will help assist the expansion of the UK veterinary drug residues surveillance programme. 

Pereira SP, Williams R. Adverse events associated with vitamin Kl results of a worldwide postmarketing surveillance programme. Pharmacoepidemiol Drug Saf 1998 7(3) 173-82. 

The six programmes that constitute the TTP are the Pharmaceutical Assessment responsible for premarket evaluation of drugs the Medical Devices Programme responsible for the administration and enforcement of the new medical devices regulations the Biologies and Radiopharmaceuticals Bureau Drug Surveillance Compliance and Enforcement and the Policy and Coordination Division. 

WHO Global Tuberculosis Programme, Geneva. Antituberculosis drug resistance in the world. The WHO/ lUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance, 1994-1997. 

---